Collection 

Pharmacogenomics for precision medicine

Submission status
Open

Healthcare is gradually moving away from a one-size fits all approach to a greater focus on patients as individuals. Precision medicine aims to identify subpopulations of patients that will best respond to specific treatments in order to optimise care. Pharmacogenomics, the study of genome variation in drug response, is a key tool in meeting this aim.

This Collection will present recently identified genomic pathways, novel genetic biomarkers, and epigenetic signals that influence treatment outcomes for particular patient populations.

Submit manuscript
Submission guidelines
Manuscript editing services
Pharmaceutical research developing genetic medicine, illustrating how medicine will be designed to cure individuals health by analysing DNA - stock photo

Editors

  • Mayumi Ueta  &

    Mayumi Ueta

    Kyoto Prefectural University of Medicine, Japan

  • Wei-Qi Wei

    Wei-Qi Wei

    Vanderbilt University Medical Center (VUMC), USA

Articles will be displayed here once they are published.